NDEWS Deputy Director, Dr. Joseph Palamar, presented along with Dr. Joshua DeBord of the Center for Forensic Science Research and Education (CFSRE) on monitoring of drug trends in the US, during the Trends, Analysis, & Threats webinar, hosted by the Overdose Response Strategy (ORS) Program.
NIDA T32 Predoctoral trainee Vijaya L. Seegulam graduated Friday, August 8, with her PhD in Epidemiology from the University of Florida. Additionally, in July, NDEWS MPI Dr. Joseph Palamar was promoted to Professor of Population Health at NYU Langone Health. Congratulations to Drs. Seegulam and Palamar.
7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat report by the FDA highlights the work of NDEWS' Web Monitoring team
Following the NDEWS 4th Annual Summit, members of the NDEWS Coordinating Center (CC) will present a late-breaking abstract, an oral presentation, symposiums, and posters showcasing our latest data while at CPDD. In addition to presenting at CPDD, NDEWS Director, Dr. Linda Cottler (MPI), will deliver the keynote during the 2025 CPDD/RSA Joint Program focusing on NDEWS.
Teen nonmedical misuse of medications may be more common than we believed. In Psychology Today’s Addiction Outlook column, Dr. Mark Gold discusses that teen nonmedical misuse of medications like dextromethorphan (DXM) and promethazine may be more widespread than previously recognized. Dr. Linda B. Cottler, Director of NDEWS, warns, “Parents…
Jim Hall is a retired epidemiologist who worked for 35 years at Nova Southeastern University in Davie, Florida, and since 1982 has served as director of the Up Front Drug Information Center in Miami. From 1984 to 2014, he served as the Florida representative to the NIDA Community Epidemiology Work Group (CEWG), the predecessor to NDEWS. Through Nova Southeastern University, Hall more recently served as a consultant with the United Way of Broward County’s Commission on Behavioral Health and Drug Prevention, formerly the Commission on Substance Abuse, which was one of the earliest drug-free community programs that is part of the Community Anti-Drug Coalitions of America (CADCA).
In April 2020, the second iteration of the NIDA-funded NDEWS was awarded to our team at the University of Florida, New York University, and Florida Atlantic University. We published our first ever NDEWS Weekly Briefing on August 28, 2020. Now on September 20, 2024, we celebrate the publication of our 200th issue of the NDEWS Weekly Briefing. We thank our readers for their support!
A study recently published in the American Journal of Preventive Medicine, authored by NDEWS Deputy Director, Dr. Joseph Palamar, examined data from the 2022 National Survey on Drug Use and Health. The results showed that while the prevalence of illicitly manufactured fentanyl use is rare in the general US population, past-year…
A study recently published in Drug and Alcohol Dependence, co-authored by NDEWS researchers Dr. Joseph Palamar, Dr. Nicole Fitzgerald, Dr. Linda Cottler, and NDEWS affiliate Dr. Tom Carr, examined overall and drug-specific associations between county-level fentanyl burden––based on seizures of fentanyl in pills and powder, pills-only, or powder only––and…
The 86th CPDD Annual Meeting is now over; held in Montreal this past week, the meeting had the highest attendance ever! On Saturday, we held our annual NDEWS Summit. In attendance were nearly 65 individuals in person and on Zoom. Our agenda included a welcome from NIDA, updates from the…
